Predicting Softgel Stability And Shelf Life Using Accelerated Stability Modeling

If you're developing softgel formulations, you already know the frustration: stability data takes time, and packaging and formulation decisions can't always wait. Accelerated predictive stability modeling offers a way out of that bottleneck, and this ibuprofen softgel case study shows exactly what's possible.

Using ASAPprime software and modified Arrhenius kinetics within the OSD Predict framework, samples of 200 mg and 400 mg ibuprofen softgels were stress-tested across temperature ranges of 40–80°C and humidity levels of 11–75% RH over just 21 days. Validated HPLC analysis quantified impurity formation, revealing multiple degradant species including ibuprofen sorbitol esters and PEG-related degradants.

The finding that matters most: PEG-esters were identified as the shelf-life-limiting degradation products for both dose strengths, following zero-order kinetics. Activation energy values were calculated at approximately 32.1 ± 17.6 kcal/mol. Model outputs were validated against historical ICH stability data, giving real confidence in the predictions.

The result? Estimated shelf lives of 5.5 years for the 200 mg formulation and 3.8 years for the 400 mg, well before any long-term study concluded. Download the full case study to see how this approach can compress your stability timeline.